Stay updated on MUKnineb: OPTIMUM Treatment Protocol Clinical Trial

Sign up to get notified when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The MUK Nine b: OPTIMUM record for high-risk multiple myeloma is displayed instead of an error page, with its study design, treatment regimen, eligibility requirements, outcome measures, and participating locations.
    Difference
    82%
    Check dated 2026-11-11T01:44:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:57:58.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page continues to show a 403 error instead of the study record, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:07:05.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:08:01.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Previously, the page showed a 403 Forbidden error, blocking access to the study record. The error page content was removed, and the study details are now accessible.
    Difference
    0.5%
    Check dated 2026-09-30T00:14:06.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the prior study details with a generic error screen. The layout includes the standard site header/footer around the 403 message, indicating the content is inaccessible.
    Difference
    21%
    Check dated 2026-09-23T00:01:00.000Z thumbnail image

Stay in the know with updates to MUKnineb: OPTIMUM Treatment Protocol Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.